GlycoMimetics, Inc. 8-K Report: Key Updates for Investors - December 2024
The provided section of the financial report contains key information about GlycoMimetics, Inc. Here are the important points extracted:
- Entity Identification:
- Company Name: GlycoMimetics, Inc.
- CIK Number: 0001253689
- SEC File Number: 001-36177
- EIN: 06-1686563
- Address: 9708 Medical Center Drive, Rockville, MD 20850
- Phone Number: 240-243-1201
- Filing Details:
- Filing Type: 8-K
- Filing Date: December 19, 2024
- Stock Information:
- Common Stock Par Value: $0.001
- Stock Symbol: GLYC
- Exchange: NASDAQ
- Reporting Period:
- Start Date: December 19, 2024
- End Date: December 19, 2024
This information indicates that GlycoMimetics, Inc. filed an 8-K on December 19, 2024, which is a report that companies must file with the SEC to announce major events that shareholders should know about. The report is dated for the same day, suggesting it may be an immediate disclosure. The details about the stock indicate it is publicly traded on NASDAQ under the symbol GLYC.
Overall, this filing may contain significant updates that could impact investors' perceptions and decisions regarding GlycoMimetics, Inc.